scorecardMed tech startup that can detect early stage dementia raises $2.13 million
  1. Home
  2. business
  3. startups
  4. news
  5. Med tech startup that can detect early stage dementia raises $2.13 million

Med tech startup that can detect early stage dementia raises $2.13 million

Med tech startup that can detect early stage dementia raises $2.13 million
Business2 min read
BCCL
  • In-Med Prognostics provides neuro analysis that can help in the assessment and early detection of neurological disorders such as Dementia, Alzheimer’s and Parkinson’s
  • The startup will use the funds to stabilize and expand the product portfolio and tap global markets.
  • Scientists have discovered that it is possible to detect dementia nine years ahead of its onset.
In-Med Prognostics, a California-based health tech company powered by AI has raised $2.13 million led by Exxora, with participation from prominent angels.

In-Med Prognostics provides time saving neuro analysis, helping in the assessment and early detection of neurological disorders such as Dementia, Alzheimer’s and Parkinson’s at affordable prices through deep learning algorithms and machine learning.

In a report by the University of Cambridge, scientists have discovered that it is possible to detect dementia nine years ahead of its onset. Recently, 39-year-old Australian actor Chris Hemsworth, popular for his playing Thor in Marvel films, took a break from acting after discovering that he was at heightened risk of developing Alzheimers.

In-Med India was founded in 2018 by Latha Poonamallee, PhD from Case Western Reserve University, Professor and Fulbright Scholar, serial entrepreneur Rajesh Purushottam and Al Curran, PhD, Stanford University. In-Med Inc, the US holding company was formed in 2021.

“We are beyond thrilled about putting this investment to good use and strengthen and broaden our product suite and go further in our mission to bring accessible state of the art AI based healthcare tools to the emerging world and beyond,” Dr. Latha Poonamallee, co-founder In-Med Prognostics, said.

The company stated that it will use the funds to stabilize and expand the product portfolio and tap global markets.

“We continue to invest in start-ups like In-Med Prognostics that are providing innovative solutions in the area of preventive brain health using AI & Deep learning (DL),” Sriram Natarajan, Exxora, added.

In India, In-Med Prognostics is working with Aarthi Scans, Scansworld, Gujarat Scans, Nanavati and Cauvery hospitals. The company is expanding to Africa and is targeting a global multi billion diagnostic and wellness market, it said.

READ MORE ARTICLES ON




Advertisement